Locations:

Tag: diffuse large b-cell lymphoma

Chimeric antigen receptor (CAR) therapy,

December 14, 2021/Cancer/Blood Cancers

Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma

Treatment may be a lifesaving option for patients with relapsed or refractory disease

March 11, 2019/Cancer/Blood Cancers

R-EPOCH May Extend Survival in Patients with Rare Forms of Diffuse Large B-Cell Lymphoma

Prospective study shows improved outcomes

BackPage 2 of 2Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy